0001356576-22-000038.txt : 20220504 0001356576-22-000038.hdr.sgml : 20220504 20220503181207 ACCESSION NUMBER: 0001356576-22-000038 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220503 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220504 DATE AS OF CHANGE: 20220503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 22888741 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 8-K 1 supn-20220503.htm 8-K supn-20220503
false000135657600013565762022-05-032022-05-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 3, 2022
 
Supernus Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)
Delaware
001-3551820-2590184
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
9715 Key West Ave
Rockville
MD
20850
(Address of Principal Executive Offices)
(Zip Code)

Registrant’s telephone number, including area code: (301) 838-2500
 
Not Applicable
(Former name or former address, if changed since last report.)

  Securities registered pursuant to Section 12(b) of the Exchange Act
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.001 par value per shareSUPNThe Nasdaq Stock Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02 Results of Operations and Financial Conditions.
On May 2, 2022, Supernus Pharmaceuticals, Inc. issued a press release announcing that it expects to report its business results for the first quarter 2022 after the market closes on Monday, May 9, 2022. The Company will host a conference call and webcast on Monday, May 9, 2022 at 4:30 p.m. E.T. to discuss its first quarter 2022 business and financial results. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
ExhibitDescription
99.1
Press Release Dated May 2, 2022 filed as an Exhibit pursuant to Item 2.02 hereof.
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
2

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 SUPERNUS PHARMACEUTICALS, INC.
  
DATED: May 3, 2022By:/s/ Timothy C. Dec
  Timothy C. Dec
Senior Vice-President and Chief Financial Officer
3
 EX-99.1 2 ex99105-02x2022.htm EX-99.1 Document

Exhibit 99.1
 image_0.jpg

Supernus Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host
Conference Call on May 9, 2022

ROCKVILLE, Md., May 2, 2022 - Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report financial and business results for the first quarter of 2022 after the market closes on Monday, May 9, 2022.

Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call to present the first quarter 2022 financial and business results on Monday, May 9, 2022 at 4:30 p.m. ET. Following management’s prepared remarks and discussion of business results, the call will be open for questions.

A live webcast will be available in the Events & Presentation section of the Supernus website at www.supernus.com.

Please refer to the information below for conference call dial-in information. Callers should dial in approximately 10 minutes prior to the start of the call.
Conference dial-in:(877) 288-1043
International dial-in:(970) 315-0267
Conference ID:
9693726
Conference Call Name:
Supernus Pharmaceuticals First Quarter 2022 Results Conference Call
Following the live call, a replay will be available on the Company’s website, www.supernus.com, under the Investor Relations section. The webcast will be available on the Company’s website for 60 days following the live call.

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.

Our diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, ADHD, hypomobility in Parkinson’s disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. We are developing a broad range of novel CNS product candidates including new potential treatments for hypomobility in PD, epilepsy, depression, and other CNS disorders.

For more information, please visit www.supernus.com.

CONTACTS:

Jack A. Khattar, President and CEO
Tim Dec, Senior Vice President and CFO
Supernus Pharmaceuticals, Inc.
Tel: (301) 838-2591

or

INVESTOR CONTACT:
Peter Vozzo
ICR Westwicke
Office: (443) 213-0505
Mobile: (443) 377-4767
Email: peter.vozzo@westwicke.com

 EX-101.SCH 3 supn-20220503.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 supn-20220503_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity Filer Name Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Document Type Document Type City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 5 supn-20220503_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 image_0.jpg begin 644 image_0.jpg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�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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover Page
May 03, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 03, 2022
Entity Registrant Name Supernus Pharmaceuticals, Inc.
Entity Incorporation, State or Country Code DE
Entity Filer Name 001-35518
Entity Tax Identification Number 20-2590184
Entity Address, Address Line One 9715 Key West Ave
Entity Address, City or Town Rockville
Entity Address, State or Province MD
Entity Address, Postal Zip Code 20850
City Area Code 301
Local Phone Number 838-2500
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol SUPN
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001356576
XML 8 supn-20220503_htm.xml IDEA: XBRL DOCUMENT 0001356576 2022-05-03 2022-05-03 false 0001356576 8-K 2022-05-03 Supernus Pharmaceuticals, Inc. DE 001-35518 20-2590184 9715 Key West Ave Rockville MD 20850 301 838-2500 Common Stock, $0.001 par value per share SUPN NASDAQ false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 22 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.supernus.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports supn-20220503.htm ex99105-02x2022.htm supn-20220503.xsd supn-20220503_lab.xml supn-20220503_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "supn-20220503.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "supn-20220503.htm" ] }, "labelLink": { "local": [ "supn-20220503_lab.xml" ] }, "presentationLink": { "local": [ "supn-20220503_pre.xml" ] }, "schema": { "local": [ "supn-20220503.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "supn", "nsuri": "http://www.supernus.com/20220503", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "supn-20220503.htm", "contextRef": "i5e51dc3567844eb994f77e5069329f1d_D20220503-20220503", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.supernus.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "supn-20220503.htm", "contextRef": "i5e51dc3567844eb994f77e5069329f1d_D20220503-20220503", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity Filer Name" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.supernus.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001356576-22-000038-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001356576-22-000038-xbrl.zip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end